EIM
PHAS

Essex Investment Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Essex Investment Management’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,000
Closed -$83K – 520
2019
Q3 		$83K Hold
20,000
– – 0.01% 379
2019
Q2 		$262K Buy
+20,000
New +$262K 0.04% 348